Literature DB >> 17965972

Ascorbic acid inhibits the migration of Walker 256 carcinosarcoma cells.

Ewa Wybieralska1, Monika Koza, Jolanta Sroka, Jarosław Czyz, Zbigniew Madeja.   

Abstract

The results of several experimental studies have shown that ascorbic acid inhibits tumor growth and metastasis. Ascorbic acid is an antioxidant that acts as a scavenger for a wide range of reactive oxygen species (ROS). Both tumour metastasis and cell migration have been correlated with the intracellular ROS level, so it was postulated that the inhibitory effect of ascorbic acid derivatives on cell motility may be caused by scavenging of ROS. Time-lapse analyses of Walker 256 carcinosarcoma cell migration showed that both the speed of movement and the cell displacement were inhibited by ascorbic acid applied in concentrations ranging from 10 to 250 microM. This effect correlated with a reduction in the intracellular ROS level in WC 256 cells, suggesting that ROS scavenging may be a mechanism responsible for the inhibition of WC 256 cell migration. However, another potent antioxidant, N-acetyl-L-cysteine, also efficiently decreased the intracellular ROS level in WC 256 cells, but did not affect the migration of the investigated cells. These results demonstrate that intact, unmodified ascorbic acid applied in physiologically relevant and non-toxic concentrations exerts an inhibitory effect on the migration of WC 256 carcinosarcoma cells, and that this may be one of the factors responsible for the anti-metastatic activity of vitamin C. However, our data does not support the hypothesis that the scavenging of intracellular ROS is the main mechanism in the inhibition of cancer cell migration by ascorbic acid.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17965972      PMCID: PMC6275902          DOI: 10.2478/s11658-007-0040-z

Source DB:  PubMed          Journal:  Cell Mol Biol Lett        ISSN: 1425-8153            Impact factor:   5.787


  2 in total

1.  Proteomic analysis of tumor tissue in CT-26 implanted BALB/C mouse after treatment with ascorbic acid.

Authors:  Jihye Lee; Gunsup Lee; Jin Hee Park; Sukchan Lee; Chang-Hwan Yeom; Byungjo Na; Seyeon Park
Journal:  Cell Mol Biol Lett       Date:  2011-12-02       Impact factor: 5.787

Review 2.  Combined inhalational and oral supplementation of ascorbic acid may prevent influenza pandemic emergency: a hypothesis.

Authors:  Dibyajyoti Banerjee; Deepak Kaul
Journal:  Nutrition       Date:  2010-01       Impact factor: 4.008

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.